Related Experiment Videos
The SERPINE2 gene is associated with chronic obstructive pulmonary disease
Dawn L Demeo1, Thomas J Mariani, Christoph Lange
1Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA. dawn.demeo@channing.harvard.edu
American Journal of Human Genetics
|December 17, 2005
Summary
Genetic analysis identified SERPINE2 as a susceptibility gene for chronic obstructive pulmonary disease (COPD). This finding suggests SERPINE2 plays a role in COPD development, potentially influenced by smoking interactions.
Area of Science:
- Genetics
- Pulmonology
- Molecular Biology
Background:
- Chronic obstructive pulmonary disease (COPD) is a complex condition with genetic and environmental influences.
- Severe alpha 1-antitrypsin deficiency is the only established genetic risk factor for COPD.
- Previous studies linked COPD phenotypes to chromosome 2q.
Purpose of the Study:
- To identify novel genetic susceptibility factors for COPD.
- To investigate the role of SERPINE2 in COPD pathogenesis.
Main Methods:
- Integrated murine lung development, human gene expression, and linkage data to identify candidate genes.
- Performed family-based association testing and case-control replication studies.
- Analyzed single-nucleotide polymorphisms (SNPs) and haplotypes within the SERPINE2 gene.
- Assessed the impact of associated SNPs on linkage models, particularly in smokers.
Main Results:
- SERPINE2 was identified as a positional candidate gene for COPD.
- SERPINE2 protein expression was confirmed in lung tissue.
- Significant association between SERPINE2 SNPs and COPD phenotypes was observed in family-based studies.
- Replication of association was found in a separate case-control study.
- Gene-by-smoking interaction was suggested by LOD score attenuation in smokers.
Conclusions:
- SERPINE2 is a significant COPD-susceptibility gene.
- The identified genetic associations suggest a role for SERPINE2 in COPD development.
- Gene-by-smoking interactions may influence SERPINE2's contribution to COPD risk.